Rgene Corporation
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Evaluate the Safety and Efficacy of BLEX 404 Oral Liquid Combined With Pemetrexed + Cisplatin Therapy (NCT05764928) | Rgene Corporation | 2026-12-01 |
| A Phase II, EvaluateBLEX 404 Combined With Gemcitabine Monotherapy With Pancreatic Cancer (NCT03301805) | Rgene Corporation | 2026-07-01 |
Track Rgene Corporation automatically
Every clearance here is in the API, with alerts when new ones post.